UAL
63
-9
HSIC
39
-11
HSY
31
-6
LUV
39
-4
MNST
44
-2
HAS
26
-6
ECL
50
-5
AEP
39
-4
C
48
-9
DE
46
-9
ORCL
45
-5
EXPD
29
-5
WDC
38
-4
DGX
22
-6
HPE
42
-11
HCP
47
-2
KSS
33
-3
LEG
14
-7
HBI
50
-6
MTCH
33
-7
UAL
63
-9
HSIC
39
-11
HSY
31
-6
LUV
39
-4
MNST
44
-2
HAS
26
-6
ECL
50
-5
AEP
39
-4
C
48
-9
DE
46
-9
ORCL
45
-5
EXPD
29
-5
WDC
38
-4
DGX
22
-6
HPE
42
-11
HCP
47
-2
KSS
33
-3
LEG
14
-7
HBI
50
-6
MTCH
33
-7
Financhill
Back

SELLAS Life Sciences Group Quote, Financials, Valuation and Earnings

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here
Sell
16

SLS
SELLAS Life Sciences Group

Last Price:
0.87
Seasonality Move:
-4.3%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

SELLAS Life Sciences Group Price Quote

$0.87
+0.01 (+1.43%)
(Updated: December 19, 2024 at 11:05 AM ET)

SELLAS Life Sciences Group Key Stats

Sell
16
SELLAS Life Sciences Group (SLS) is a Sell
Day range:
$0.84 - $0.92
52-week range:
$0.50 - $1.72
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.9%
Volume:
1.5M
Avg. volume:
1.4M
1-year change:
-23.42%
Market cap:
$62.1M
Revenue:
$0
EPS:
$-0.69

How Much Does SELLAS Life Sciences Group Make?

Data Unavailable

Is SELLAS Life Sciences Group Growing As A Company?

Data Unavailable

SELLAS Life Sciences Group Stock Price Performance

What Is SELLAS Life Sciences Group 52-Week High & Low?

SELLAS Life Sciences Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy SELLAS Life Sciences Group?

Is SELLAS Life Sciences Group Cash Flow Positive?

  • What Is SLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$33.1M
  • What Is SELLAS Life Sciences Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $50.1M
  • What Is SELLAS Life Sciences Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

SELLAS Life Sciences Group Return On Invested Capital

Data Unavailable

SELLAS Life Sciences Group Earnings Date & Stock Price

SELLAS Life Sciences Group Competitors

SELLAS Life Sciences Group Dividend Yield

SELLAS Life Sciences Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 21.06%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.83
Upside from Last Price: 580.11%

Major Shareholders

  • How many SLS shares are owned by institutional investors?
    8.2M SLS shares are owned by institutional investors
  • How many SLS shares are owned by insiders?
    2.4M SLS shares are owned by insiders